Form 4: PetMed Express CEO Sandra Campos Acquires Shares Through Incentive Plan

PetMed Express CEO Sandra Campos acquired 146,772 shares of common stock and 146,772 performance share units through the company's 2024 Omnibus Incentive Plan.

Summary

• Sandra Campos, CEO and President of PetMed Express, acquired 146,772 shares of common stock and 146,772 performance share units on January 15, 2025.
• The common stock was acquired through restricted stock units (RSUs) granted under the company's 2024 Omnibus Incentive Plan.
• One-third of the RSUs will vest annually on the first, second, and third anniversaries of January 15, 2025, contingent on continued employment.
• Each RSU represents the right to receive one share of PetMed Express common stock upon vesting.
• The performance share units (PSUs) were also granted under the plan and represent a contingent right to receive one share of common stock.
• The PSUs will vest if predetermined levels of the company's total shareholder return relative to the S&P 600 Specialty Retail Index are achieved over a three-year period ending December 31, 2027.

Sentiment

Score: 7

Explanation: The document reflects a positive sentiment as it shows the CEO's increased stake in the company through equity grants, aligning her interests with shareholders. The performance-based component also suggests a focus on long-term value creation.

Positives

• The acquisition of shares by the CEO demonstrates alignment of interests with shareholders.
• The vesting schedule of the RSUs encourages long-term commitment from the CEO.
• The performance-based vesting of PSUs incentivizes the CEO to drive shareholder value.

Risks

• The vesting of the RSUs is contingent on continued employment, which could be a risk if the CEO were to leave the company.
• The vesting of the PSUs is dependent on the company's performance relative to the S&P 600 Specialty Retail Index, which is subject to market fluctuations.

Future Outlook

The document outlines the vesting schedule for the acquired shares and performance share units, indicating future potential ownership changes based on time and performance.

Industry Context

This type of equity-based compensation is common in publicly traded companies to align management's interests with those of shareholders and incentivize performance.

Comparison to Industry Standards

• Equity-based compensation, such as RSUs and PSUs, is a standard practice among publicly traded companies like PetMed Express.
• Companies such as Chewy and Zoetis also use similar incentive plans to reward and retain key executives.
• The vesting schedules and performance metrics used by PetMed Express are comparable to those used by its peers in the specialty retail and animal health industries.

Stakeholder Impact

• Shareholders may view the CEO's increased stake as a positive sign of commitment and alignment of interests.
• Employees may see the equity grants as a sign of the company's commitment to its leadership.
• The performance-based vesting of PSUs could lead to increased focus on shareholder value.

Next Steps

• The vesting of the RSUs will occur annually on January 15, 2026, 2027 and 2028.
• The performance of the company will be measured against the S&P 600 Specialty Retail Index until December 31, 2027, to determine the vesting of the PSUs.

Key Dates

Keywords

PetMed Express, Sandra Campos, CEO, restricted stock units, performance share units, incentive plan, shareholder return, S&P 600 Specialty Retail Index, vesting